Gain Therapeutics Inc. (GANX)
undefined
undefined%
At close: undefined
1.50
-7.98%
Pre-market Dec 16, 2024, 04:03 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 55.18K 140.11K 164.99K 28.88K 41.30K 20.61K
Cost of Revenue 80.38K 64.17K 7.16M 2.26M - -
Gross Profit -25.20K 75.94K -7.00M -2.23M 41.30K 20.61K
Operating Income -22.25M -17.78M -13.83M -3.48M -2.10M -1.03M
Interest Income 494.23K 375.36K 12.49K 3.64K 20.54K -
Pretax Income -22.19M -17.50M -13.89M -3.57M -2.19M -1.10M
Net Income -22.27M -17.59M -13.89M -3.58M -2.19M -1.11M
Selling & General & Admin 10.79M 9.54M 6.83M 1.25M 555.16K 222.05K
Research & Development 11.52M 8.38M 7.16M 2.26M 1.59M 826.88K
Other Expenses - - - - - -
Operating Expenses 22.31M 17.92M 13.99M 3.51M 2.14M 1.05M
Interest Expense - - - - 20.54K -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 22.31M 17.92M 13.99M 3.51M 2.14M 1.05M
Income Tax 79.28K 92.98K 4.01K 5.39K 7.11K 9.78K
Shares Outstanding (Basic) 13.01M 11.88M 10.17M 11.88M 11.88M 5.86M
Shares Outstanding (Diluted) 13.01M 11.88M 10.17M 11.88M 11.88M 5.86M
EPS (Basic) -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
EPS (Diluted) -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
EBITDA -22.17M -17.78M -13.82M -3.47M -2.10M -1.03M
Depreciation & Amortization 83.58K 64.17K 15.48K 9.59K 2.57K 741.00